- Home
- ZENV vs PTHL Comparison
ZENV vs PTHL Comparison
Compare ZENV & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- PTHL
- Stock Information
- Founded
- ZENV 2005
- PTHL 1998
- Country
- ZENV Brazil
- PTHL China
- Employees
- ZENV N/A
- PTHL N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- PTHL
- Sector
- ZENV Technology
- PTHL
- Exchange
- ZENV Nasdaq
- PTHL Nasdaq
- Market Cap
- ZENV 63.3M
- PTHL 65.0M
- IPO Year
- ZENV 2021
- PTHL 2024
- Fundamental
- Price
- ZENV $1.36
- PTHL $4.74
- Analyst Decision
- ZENV
- PTHL
- Analyst Count
- ZENV 0
- PTHL 0
- Target Price
- ZENV N/A
- PTHL N/A
- AVG Volume (30 Days)
- ZENV 80.7K
- PTHL 143.7K
- Earning Date
- ZENV 11-18-2024
- PTHL 12-03-2024
- Dividend Yield
- ZENV N/A
- PTHL N/A
- EPS Growth
- ZENV N/A
- PTHL N/A
- EPS
- ZENV N/A
- PTHL N/A
- Revenue
- ZENV $173,594,726.00
- PTHL $572,291.00
- Revenue This Year
- ZENV $21.46
- PTHL N/A
- Revenue Next Year
- ZENV $9.29
- PTHL N/A
- P/E Ratio
- ZENV N/A
- PTHL N/A
- Revenue Growth
- ZENV 23.49
- PTHL 2.32
- 52 Week Low
- ZENV $0.88
- PTHL $3.32
- 52 Week High
- ZENV $3.88
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- ZENV 54.17
- PTHL N/A
- Support Level
- ZENV $1.12
- PTHL N/A
- Resistance Level
- ZENV $1.55
- PTHL N/A
- Average True Range (ATR)
- ZENV 0.12
- PTHL 0.00
- MACD
- ZENV 0.02
- PTHL 0.00
- Stochastic Oscillator
- ZENV 55.81
- PTHL 0.00
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.